Masonic Cancer Center, University of Minnesota
The Masonic Cancer Center, University of Minnesota (MCC), exists to reduce the burden of cancer on Minnesotans and beyond. We work to create a collaborative research environment focused on the causes, prevention, detection, and treatment of cancer; we apply that knowledge to improve quality of life for patients and survivors; and we share our discoveries with other scientists, students, professionals, and our community. Find out more at cancer.umn.edu
Videos
Masonic Cancer Center, University of Minnesota
Chemotherapy-Induced Hair Loss: Insights and Effective Strategies
FEATURING
Maria Hordinsky
- 128 views
- November 11, 2024
Masonic Cancer Center, University of Minnesota
Transforming Cancer Care Through Data
FEATURING
Samuel Volchenboum
- 2 views
- November 11, 2024
Masonic Cancer Center, University of Minnesota
Proteomic Approaches to Nominate Drug Targets and Assess Biomarkers in Prostate Cancer
FEATURING
Justin Drake
- 22 views
- November 7, 2024
Masonic Cancer Center, University of Minnesota
Targeting RET Kinase in Neuroendocrine Prostate Cancer
FEATURING
Justin Drake
- 2 views
- November 7, 2024
Masonic Cancer Center, University of Minnesota
The Genetic Epidemiology and Early-Life Origins of Childhood Leukemia
FEATURING
Adam de Smith
- 8 views
- October 8, 2024
Masonic Cancer Center, University of Minnesota
Blood Cancers Basics
FEATURING
Zohar Sachs
- 21 views
- October 7, 2024
Masonic Cancer Center, University of Minnesota
Canine Cancer Immunotherapy: Linking Mouse and Human Using Dog Natural Killer Cells
FEATURING
Robert Canter
- 14 views
- August 2, 2024
Masonic Cancer Center, University of Minnesota
Sleepwalking Through Evolution: A Tale of Dormancy and Hormone Dependent Breast Cancer
FEATURING
Luca Magnani
- 115 views
- August 2, 2024
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center Cardio-Oncology Updates
FEATURING
Suma Konety
- 25 views
- June 7, 2024
Masonic Cancer Center, University of Minnesota
The Role of Autologous Transplant and Cellular Therapy for Solid Tumors in 2024
FEATURING
Nicholas Zorko
- 77 views
- June 7, 2024
- 1
Masonic Cancer Center, University of Minnesota
Current Status of Head and Neck Cancers
FEATURING
Frank Ondrey
- 124 views
- May 23, 2024
Masonic Cancer Center, University of Minnesota
Overview of Ovarian Cancer Updates
FEATURING
Jordan Mattson
- 276 views
- May 23, 2024
- 2
Masonic Cancer Center, University of Minnesota
Overview of Uterine/Endometrial Cancer Updates
FEATURING
Jordan Mattson
- 230 views
- May 23, 2024
- 3
Masonic Cancer Center, University of Minnesota
Overview of Cervical Cancer Updates
FEATURING
Jordan Mattson
- 188 views
- May 23, 2024
- 2
Masonic Cancer Center, University of Minnesota
Overview of Vulvar/Vaginal Cancer Updates
FEATURING
Jordan Mattson
- 103 views
- May 23, 2024
Masonic Cancer Center, University of Minnesota
Disparities in Gynecologic Cancers
FEATURING
Jordan Mattson
- 65 views
- May 23, 2024
Masonic Cancer Center, University of Minnesota
Understanding Variations in Risk of Lung Cancer Among Smokers
FEATURING
Jian-Min Yuan
- 127 views
- May 22, 2024
- 3
Masonic Cancer Center, University of Minnesota
Pathways to Prevention: Strategies to Address Cancer Disparities in Cultural Groups in MN
FEATURING
Serena Xiong
- 25 views
- March 14, 2024
- 1
Masonic Cancer Center, University of Minnesota
Lung Cancer Prevention: Tobacco Cessation & Prevention
FEATURING
April Wilhelm
- 225 views
- March 14, 2024
- 1
Masonic Cancer Center, University of Minnesota
Preventing and Remediating Accelerated Aging in Survivors of Childhood Cancer
FEATURING
Kirsten Ness
- 44 views
- March 14, 2024
Masonic Cancer Center, University of Minnesota
From Rare to Well-Done: The Epidemiology of Ewing Sarcoma
FEATURING
Logan Spector
- 80 views
- March 1, 2024
Masonic Cancer Center, University of Minnesota
Innate Lymphoid Cells and Cancer: What’s the Connection?
FEATURING
Michael Caligiuri
- 29 views
- February 23, 2024
Masonic Cancer Center, University of Minnesota
Biomarkers and Biology: Treatment Resistance in Advanced Prostate Cancer
FEATURING
Joshua Lang
- 272 views
- February 20, 2024
- 1
Masonic Cancer Center, University of Minnesota
ALL: The Changing Shape of MRD
FEATURING
Sean Tracy
- 97 views
- January 24, 2024
Masonic Cancer Center, University of Minnesota
CMV and Patient-Reported Outcomes in Ovarian Cancer
FEATURING
Rachel Vogel
- 75 views
- December 13, 2023
Masonic Cancer Center, University of Minnesota
Drug Targets and Synthetic Vulnerabilities in Sarcoma: Our Experience in NF1
FEATURING
David Largaespada
- 84 views
- December 12, 2023
Masonic Cancer Center, University of Minnesota
Hormone Deficiencies After Cancer: Diagnosis, Risks, & Benefits of Treatment
FEATURING
Bradley Miller
- 214 views
- May 22, 2023
- 3
Masonic Cancer Center, University of Minnesota
The Time Toxicity of Cancer Care
FEATURING
Arjun Gupta
- 84 views
- May 4, 2023
- 3
Masonic Cancer Center, University of Minnesota
Can We Eliminate Cervical Cancer?
FEATURING
Shalini Kulasingam
- 128 views
- May 4, 2023
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center Updates on the Colorectal Cancer Research
FEATURING
Subree Subramanian
- 58 views
- May 4, 2023
- 1
ASCO GU 2023 Conference Coverage
ASCO GU 2023 Real-World Assessment of AR-LBD Mutations in mCRPC
FEATURING
Emmanuel Antonarakis
- 64 views
- March 8, 2023
- 1
Masonic Cancer Center, University of Minnesota
Improving Care Delivery and Outcomes for Older Patients With Cancer and Their Caregivers
FEATURING
Supriya Mohile
- 46 views
- March 7, 2023
- 1
Masonic Cancer Center, University of Minnesota
The Microtubule Severing Protein UNC-45A in Cancer and Neurodegenerative Diseases
FEATURING
Martina Bazzaro
- 4 views
- January 20, 2023
Masonic Cancer Center, University of Minnesota
Unraveling the Proteome of Extracellular Vesicles in Prostate Cancer
FEATURING
Megan Ludwig
- 17 views
- January 19, 2023
Masonic Cancer Center, University of Minnesota
The Role of Mineralocorticoid Receptor Signaling in TNBC
FEATURING
Julia Austin
- 46 views
- January 18, 2023
Masonic Cancer Center, University of Minnesota
Mechanisms of Progression and Aggressive Biology of TP53-Mutated AML
FEATURING
Zohar Sachs
- 64 views
- January 4, 2023
- 1
ASH 2022 Conference Coverage
ASH 2022 Gene Edited Off-the-Shelf NK Cells for Treating Hematologic Disease
FEATURING
Jeffrey Miller
- 80 views
- January 4, 2023
Masonic Cancer Center, University of Minnesota
The Obesity Paradox in Cancer Immunotherapy: Linking Preclinical and Clinical Data
FEATURING
William Murphy
- 15 views
- December 2, 2022
Masonic Cancer Center, University of Minnesota
Germline TP53 Variants & Cancer: Lessons Learned From Li-Fraumeni Syndrome
FEATURING
Sharon Savage
- 25 views
- November 10, 2022
- 1
Masonic Cancer Center, University of Minnesota
Cooked Meat and Prostate Cancer
FEATURING
Robert Turesky
- 2,346 views
- November 4, 2022
- 5
Masonic Cancer Center, University of Minnesota
Breast Cancer Imaging Updates
FEATURING
Miss Ekwochi
- 394 views
- October 27, 2022
- 4
Masonic Cancer Center, University of Minnesota
The Innate and Adaptive Responses of NK Cells
FEATURING
Joseph Sun
- 7 views
- October 24, 2022
Masonic Cancer Center, University of Minnesota
Role of the Growth Hormone/IGF-1 Axis in Breast and Prostate Cancers
FEATURING
Paul Marker
- 37 views
- September 30, 2022
Masonic Cancer Center, University of Minnesota
Molecular Biology, Epidemiology, and Causes of Bone Cancer
FEATURING
Logan Spector
- 29 views
- August 25, 2022
Masonic Cancer Center
Understanding Intravascular Delivery of Adenovirus Gene Therapy Vectors
FEATURING
Andrew Byrnes
- 1 view
- June 9, 2022
Masonic Cancer Center, University of Minnesota
Optimal Dose Determination in Phase 1 Clinical Trials
FEATURING
Patricia LoRusso
- 10 views
- June 9, 2022
Masonic Cancer Center, University of Minnesota
New Therapeutic Discoveries and Mechanisms for CRPC
FEATURING
Kathleen Kelly
- 91 views
- June 6, 2022
Masonic Cancer Center, University of Minnesota
Clonal Hematopoiesis
FEATURING
Amy DeZern
- 24 views
- June 6, 2022
Masonic Cancer Center, University of Minnesota
State of the Masonic Cancer Center - 2022 MCC Annual Research Symposium
FEATURING
Douglas Yee
- 12 views
- June 2, 2022
Masonic Cancer Center, University of Minnesota
EGFRm NSCLC: Resistance Mechanisms, Role of DARPP-32 in Tumor Growth
FEATURING
Luke Hoeppner
- 48 views
- May 26, 2021
Masonic Cancer Center
Clinical Application of Genome Editing: TIL Therapy, CISH, CRISPR/Cas9 and T Cells
FEATURING
Beau Webber
- 6 views
- May 19, 2021
Masonic Cancer Center, University of Minnesota
AR Alternative Polyadenylation as a Therapeutic Vulnerability in Prostate Cancer
FEATURING
Kiel Tietz
- 10 views
- May 17, 2021
Masonic Cancer Center, University of Minnesota
A Systems Perspective on Endocrine Resistance in Breast Cancer
FEATURING
Robert Clarke
- 38 views
- May 17, 2021
Masonic Cancer Center, University of Minnesota
Targeting CD83 to Reduce AML Relapse and GVHD After alloHCT
FEATURING
Brian Betts
- 15 views
- April 18, 2022
Masonic Cancer Center, University of Minnesota
Lineage Plasticity and the Neuroendocrine Phenotype in Prostate Cancer
FEATURING
Himisha Beltran
- 13 views
- April 13, 2021
Masonic Cancer Center
Two-Hit Models to Understand the Mechanisms of Latent Doxorubicin Cardiotoxicity
FEATURING
Beshay Zordoky
- 4 views
- April 13, 2021
